1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 379 F.Supp.3d
  5. 379 F.Supp.3d 198 (2019)
 

IN RE MYLAN N.V. SECURITIES LITIGATION

16-CV-7926 (JPO).

379 F.Supp.3d 198 (2019)

IN RE MYLAN N.V. SECURITIES LITIGATION.

United States District Court, S.D. New York.

Signed March 29, 2019.

Editors Note
Applicable Law: 15 U.S.C. § 78m(a)
Cause: 15 U.S.C. § 78m(a) Securities Exchange Act
Nature of Suit: 850 Securities / Commodities
Source: PACER

Attorney(s) appearing for the Case

Stef Van Duppen, Individually & Stef Van Duppen, On behalf of others similarly situated, Plaintiffs, represented by Phillip C. Kim , The Rosen Law Firm P.A.

Landon W. Perdue, Individually and on behalf of all others similarly situated, Consolidated Plaintiff, represented by Jeremy Alan Lieberman , Pomerantz LLP & Joseph Alexander Hood, II , Pomerantz LLP.

Dan Kleinerman, Co-Lead Plaintiff's, Movant, represented by Daniel Stephen Sommers , Cohen Milstein Sellers & Toll PLLC, Steven Jeffrey Toll , Cohen Milstein Sellers & Toll PLLC, Times Wang , Cohen Milstein Sellers & Toll PLLC & Jeremy Alan Lieberman , Pomerantz LLP.

Vladimir Tchentsov, Movant, represented by Joseph R. Seidman , Bernstein Liebhard, LLP.

Menorah Mivtachim Insurance Ltd., Menorah Mivtachim Pensions and Gemel Ltd., Phoenix Insurance Company Ltd. & Meitav DS Provident Funds and Pension Ltd., Movants, represented by Jeremy Alan Lieberman , Pomerantz LLP, Austin Patrick Van , Pomerantz LLP & Joseph Alexander Hood, II , Pomerantz LLP.

John D. Sheehan, Defendant, pro se.

Rajiv Malik, Defendant, represented by Kevin J. Orsini , Cravath, Swaine & Moore LLP.

Mylan N.V., Mylan, Inc., Heather Bresch, Robert J. Coury, Paul B. Campbell, Kenneth S. Parks & John D. Sheehan, Consolidated Defendants, represented by David R. Marriott , Cravath, Swaine & Moore LLP, Kevin J. Orsini , Cravath, Swaine & Moore LLP & Rory Ann Leraris , Cravath, Swaine & Moore LLP.

OPINION AND ORDER

A group of plaintiffs bring this putative securities class action against the drug manufacturer Mylan N.V. and several of its officers, in connection with the alleged misclassification of the EpiPen, a rebate scheme involving the EpiPen, and the alleged inflation of prices...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases